EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study

Fabian Tomschi iD, Jamil Hmida iD, Steffen Herzig, Pia Ransmann iD, Marius Brühl, Alexander Schmidt iD, Marie Herzig, Georg Goldmann, Andreas C Strauß iD, Johannes Oldenburg iD, Heinrich Richter, Thomas Hilberg iD

Haemophilia · 2024

DOI: 10.1111/hae.14965 ↗

At a glance

Beobachtungsstudie in Haemophilia, 2024. Written by Fabian Tomschi and 11 co-authors. Institution: Department of Sports Medicine, University of Wuppertal, Wuppertal, Germany. Major MEDLINE topics: Hemophilia A. Cited 7 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Takeda Pharmaceutical Company.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Regular physical activity (PA) is recommended for patients with haemophilia (PwH). For PwH it is crucial to ensure a sufficient factor level to prevent PA‐induced bleedings. However, there is a gap in the literature dealing with specific factor levels, which are needed when performing specific types of PA.

Aim

To provide data on factor VIII (FVIII) levels at the start of PA performed by PwH.

Methods

In this prospective 12‐month real‐world observational study, 23 PwH recorded every PA they performed and the FVIII levels at the start of the PA using a pharmacokinetic application. PA types were clustered according to the collision and injury risk into three categories (Cat I = low, Cat II = medium, Cat III = high risk). Haemophilia Joint Health Scores (HJHS) were performed at baseline, after 6 and 12 months.

Results

795 PA sessions of Cat I, 193 of Cat II, and 23 of Cat III were documented. FVIII levels at the start of PA were different between categories (Cat I: 29.8 ± 32.1%, Cat II: 38.3 ± 33.4%, Cat III: 86.6 ± 29.2%). Out of all PA sessions, 145 (14%) were performed at a factor level of ≤3%. Three PA‐induced bleeding occurred. Baseline HJHS was 14.5 ± 13.6 points and did not change throughout the study.

Conclusion

This study provides real‐life data on FVIII levels at the start of 1011 PA sessions. PwH are mainly active in low‐risk sports with higher FVIII levels observed in Cat II and III, respectively. Only three PA‐induced bleeding occurred, even though several PA were started with low FVIII levels.

Subjects

MeSH terms (MEDLINE)

Hemophilia AHumansFactor VIIIProspective StudiesHemorrhageExercise

Author keywords

annual bleeding ratearthropathyhaemophiliapharmacokineticsrare diseasesport

Substances

Factor VIII

Authors and institutions

  • Department of Sports Medicine, University of Wuppertal, Wuppertal, Germany.
  • Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
  • Department of Orthopaedics and Trauma Surgery, University of Bonn, Bonn, Germany.
  • Haemophilia Centre Muenster, Muenster, Germany.

ORCID profiles: Fabian Tomschi, Jamil Hmida, Pia Ransmann, Alexander Schmidt, Andreas C Strauß, Johannes Oldenburg, Thomas Hilberg

Funding

  • Takeda Pharmaceutical Company

Cite

APA

Tomschi, F., Hmida, J., Herzig, S., Ransmann, P., Brühl, M., Schmidt, A., Herzig, M., Goldmann, G., Strauß, A. C., Oldenburg, J., Richter, H., & Hilberg, T. (2024). Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study. Haemophilia. https://doi.org/10.1111/hae.14965

Vancouver

Tomschi F, Hmida J, Herzig S, Ransmann P, Brühl M, Schmidt A, et al. Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study. Haemophilia. 2024. doi:10.1111/hae.14965

BibTeX
@article{Tomschi2024,
  author = {Tomschi, Fabian and Hmida, Jamil and Herzig, Steffen and Ransmann, Pia and Brühl, Marius and Schmidt, Alexander and Herzig, Marie and Goldmann, Georg and Strauß, Andreas C and Oldenburg, Johannes and Richter, Heinrich and Hilberg, Thomas},
  title = {Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study},
  journal = {Haemophilia},
  year = {2024},
  doi = {10.1111/hae.14965}
}
Start for free →